By examining a cognitively unimpaired PD cohort, this study sought to clarify whether APOE4 is associated with adverse presymptomatic brain changes that manifest prior to PD-related cognitive impairment, potentially aiding risk identification and supporting early intervention of this non-motor symptom. This evidence concerns the gene APOE and Cognitive impairment.